Your browser doesn't support javascript.
loading
Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment.
Hodis, Eran; Torlai Triglia, Elena; Kwon, John Y H; Biancalani, Tommaso; Zakka, Labib R; Parkar, Saurabh; Hütter, Jan-Christian; Buffoni, Lorenzo; Delorey, Toni M; Phillips, Devan; Dionne, Danielle; Nguyen, Lan T; Schapiro, Denis; Maliga, Zoltan; Jacobson, Connor A; Hendel, Ayal; Rozenblatt-Rosen, Orit; Mihm, Martin C; Garraway, Levi A; Regev, Aviv.
Afiliação
  • Hodis E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Torlai Triglia E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Kwon JYH; Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA 02115, USA.
  • Biancalani T; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Zakka LR; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Parkar S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Hütter JC; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Buffoni L; Department of Dermatology, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Delorey TM; Harvard Medical School, Boston, MA 02115, USA.
  • Phillips D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Dionne D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Nguyen LT; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Schapiro D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Maliga Z; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Jacobson CA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Hendel A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Rozenblatt-Rosen O; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Mihm MC; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Garraway LA; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
  • Regev A; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Science ; 376(6592): eabi8175, 2022 04 29.
Article em En | MEDLINE | ID: mdl-35482859
ABSTRACT
Establishing causal relationships between genetic alterations of human cancers and specific phenotypes of malignancy remains a challenge. We sequentially introduced mutations into healthy human melanocytes in up to five genes spanning six commonly disrupted melanoma pathways, forming nine genetically distinct cellular models of melanoma. We connected mutant melanocyte genotypes to malignant cell expression programs in vitro and in vivo, replicative immortality, malignancy, rapid tumor growth, pigmentation, metastasis, and histopathology. Mutations in malignant cells also affected tumor microenvironment composition and cell states. Our melanoma models shared genotype-associated expression programs with patient melanomas, and a deep learning model showed that these models partially recapitulated genotype-associated histopathological features as well. Thus, a progressive series of genome-edited human cancer models can causally connect genotypes carrying multiple mutations to phenotype.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Science Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Science Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos